Biotechnology company Impel NeuroPharma revealed on Monday the election of Lynn C. Gold, PhD as the senior vice president of Regulatory Affairs.
In the senior position in the company, Gold has extensive oversight of regulatory strategy, agency communication as well as regulatory submissions
Most recently, Gold has served as vice president of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services LLC as well as vice president of its Research and Process Development at Sonus Pharmaceuticals.
Previously, Gold worked with Warner Chilcott Laboratories, Naryx Pharmaceuticals as well as Pharmacia and Upjohn.
Currently, Gold is a member of AAPS and the American Chemical Society (ACS) and Drug Information Association (DIA).
GSK releases decade-long data on Shingrix efficacy
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients